Updates are available Correction dated 2021-04-05
Click to view Correction: https://doi.org/10.1007/s10875-021-01030-6
-
Authors
Gardner, Cameron L.
Pavel-Dinu, Mara
Dobbs, Kerry
Bosticardo, Marita
Reardon, Paul K.
Lack, Justin
DeRavin, Suk See
Le, Kent
Bello, Ezekiel
Pala, Francesca
Delmonte, Ottavia M.
Malech, Harry
Montel-Hagan, Amelie
Crooks, Gay
Acuto, Oreste
Porteus, Matthew H.
Notarangelo, Luigi D. http://orcid.org/0000-0002-8335-0262
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (1 ZIA AI001222-02, Bench-to-Bedside)
Wellcome Trust (WT200844/Z/16/Z)
- License Information
-
More Information
Article History
Received: 27 December 2020
Accepted: 3 February 2021
First Online: 1 March 2021
Change Date: 5 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10875-021-01030-6
Compliance with Ethical Standards
:
: M.H.P. serves on the SAB for CRISPR Tx and Allogene Tx. Neither company had input into the design, execution, data analysis, or publication of the work presented in this manuscript. The other authors declare that they have no conflict of interest.
: A skin biopsy specimen was obtained from the RAG2-deficient patient upon informed consent according to protocol 04-09-113R approved by Boston Children’s Hospital IRB.
: Not applicable.
: Not applicable.
